申请人:Yoshitomi Pharmaceutical Industries, Ltd.
                            
                            
                                公开号:EP0311948A2
                            
                            
                                公开(公告)日:1989-04-19
                            
                            
A quinolonecarboxylic acid compound of the formula I
 wherein R¹ is an alkyl group, a cycloalkyl group, a haloalkyl group, an alkenyl group, mono- or di-alkylamino groups, a phenyl group or a substituted phenyl group by one to three substituents selected from the group consisting of a halogen atom, an alkyl group, an alkoxy group, a hydroxy group, a nitro group or an amino group, R² is a hydrogen atom, an alkyl group, a cycloalkyl group, an acyl group or an alkoxycarbonyl group, R³ is a hydrogen atom, an alkyl group or an aralkyl group, or R² and R³ together with the adjacent nitrogen atom form heterocyclic ring, R⁴ is a hydrogen atom or an alkyl group, R⁵ is a hydrogen atom, an alkyl group, an aralkyl group or an ester residue which is readily hydrolyzable in vivo, X is a hydrogen atom, a halogen atom or an alkyl group, n is integer of 1 to 3, and a salt thereof, and pharmaceutical   use thereof.
Said compounds exhibit antibacterial activities and are useful for the treatment of various infectious diseases.  
                            式 I 的
喹啉羧酸化合物
 其中 R¹ 是烷基、环烷基、卤代烷基、烯基、单或双烷基
氨基、苯基或被一至三个取代基取代的苯基,取代基可从卤原子、烷基、烷氧基、羟基、硝基或
氨基组成的组中选出;R² 是氢原子、烷基、环烷基、酰基或烷氧基羰基、R⁴ 是氢原子或烷基,R⁵ 是氢原子、烷基、芳烷基或在体内易
水解的酯残基,X 是氢原子、卤素原子或烷基,n 是 1 至 3 的整数。
上述化合物具有抗菌活性,可用于治疗各种传染性疾病。